KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Invested Capital (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 14 years of Return on Invested Capital data on record, last reported at 0.0% in Q2 2025.

  • For Q2 2025, Return on Invested Capital fell 8.0% year-over-year to 0.0%; the TTM value through Jun 2025 reached 0.0%, down 8.0%, while the annual FY2025 figure was 0.03%, 12.0% down from the prior year.
  • Return on Invested Capital reached 0.0% in Q2 2025 per JAZZ's latest filing, down from 0.08% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.1% in Q1 2021 and bottomed at 0.06% in Q3 2021.
  • Average Return on Invested Capital over 5 years is 0.03%, with a median of 0.01% recorded in 2022.
  • Peak YoY movement for Return on Invested Capital: fell -11bps in 2021, then grew 9bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.05% in 2021, then crashed by -109bps to 0.0% in 2022, then soared by 2097bps to 0.09% in 2023, then fell by -4bps to 0.08% in 2024, then tumbled by -103bps to 0.0% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.0% in Q2 2025, 0.08% in Q4 2024, and 0.08% in Q3 2024.